trial · primary record
Acetazolamide 62.5 mg
T2D
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 20 |
| Primary completion | 2028-12-01 |
| Primary endpoint | Iohexol Measured GFR |
| Registry ID | NCT07902726 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-29T14:34:22.752Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07902726
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.